Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-094832
Filing Date
2025-07-09
Accepted
2025-07-09 17:00:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3454
  Complete submission text file 0000950170-25-094832.txt   5049
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Subject) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41837 | Film No.: 251114172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address MURAL ONCOLOGY LTD. 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address
Loew Caroline (Reporting) CIK: 0001989488 (see all company filings)

Type: 144